HERON THERAPEUTICS, INC. /DE/ Shares Outstanding (Cover Page)
HERON THERAPEUTICS, INC. /DE/ (HRTX) had Shares Outstanding (Cover Page) of 189.85 million shares as of 2026-08-05, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-10
- 2026-08-05: Entity Common Stock, Shares Outstanding 189.85M shares.
- 2026-05-06: Entity Common Stock, Shares Outstanding 189.28M shares.
- 2026-02-13: Entity Common Stock, Shares Outstanding 188.54M shares.
- 2025-10-30: Entity Common Stock, Shares Outstanding 183.36M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-05 | 189.85M shares 10-Q · filed 2026-08-10 |
| 2026-05-06 | 189.28M shares 10-Q · filed 2026-05-11 |
| 2026-02-13 | 188.54M shares 10-K · filed 2026-02-26 |
| 2025-10-30 | 183.36M shares 10-Q · filed 2025-11-04 |
| 2025-07-31 | 153.29M shares 10-Q · filed 2025-08-08 |
| 2025-05-01 | 152.56M shares 10-Q · filed 2025-05-06 |
| 2025-02-13 | 152.33M shares 10-K · filed 2025-02-27 |
| 2024-11-07 | 152.09M shares 10-Q · filed 2024-11-12 |
| 2024-08-01 | 151.67M shares 10-Q · filed 2024-08-06 |
| 2024-05-02 | 150.65M shares 10-Q · filed 2024-05-07 |
| 2024-02-28 | 150.33M shares 10-K · filed 2024-03-12 |
| 2023-11-08 | 150.07M shares 10-Q · filed 2023-11-14 |
| 2023-07-25 | 140.76M shares 10-Q · filed 2023-08-14 |
| 2023-05-01 | 119.71M shares 10-Q · filed 2023-05-11 |
| 2023-03-14 | 119.26M shares 10-K · filed 2023-03-29 |
| 2022-11-01 | 118.89M shares 10-Q · filed 2022-11-08 |
| 2022-08-01 | 102.63M shares 10-Q · filed 2022-08-09 |
| 2022-05-03 | 102.48M shares 10-Q · filed 2022-05-09 |
| 2022-02-04 | 102.14M shares 10-K · filed 2022-02-28 |
| 2021-10-28 | 101.94M shares 10-Q · filed 2021-11-03 |
| 2021-07-29 | 101.91M shares 10-Q · filed 2021-08-09 |
| 2021-05-04 | 101.83M shares 10-Q · filed 2021-05-10 |
| 2021-02-05 | 91.40M shares 10-K · filed 2021-02-24 |
| 2020-10-29 | 90.86M shares 10-Q · filed 2020-11-05 |
| 2020-07-29 | 90.86M shares 10-Q · filed 2020-08-05 |
| 2020-04-29 | 90.64M shares 10-Q · filed 2020-05-06 |
| 2020-02-03 | 90.37M shares 10-K · filed 2020-03-02 |
| 2019-10-30 | 90.05M shares 10-Q · filed 2019-11-12 |
| 2019-07-17 | 79.82M shares 10-Q · filed 2019-08-05 |
| 2019-04-18 | 79.07M shares 10-Q · filed 2019-05-09 |
| 2019-02-01 | 78.18M shares 10-K · filed 2019-02-22 |
| 2018-10-26 | 78.02M shares 10-Q · filed 2018-11-07 |
| 2018-07-24 | 77.73M shares 10-Q · filed 2018-08-08 |
| 2018-04-25 | 71.95M shares 10-Q · filed 2018-05-10 |
| 2018-02-01 | 64.65M shares 10-K · filed 2018-02-27 |
| 2017-10-25 | 54.50M shares 10-Q · filed 2017-11-06 |
| 2017-07-26 | 54.14M shares 10-Q · filed 2017-08-09 |
| 2017-04-17 | 53.70M shares 10-Q · filed 2017-05-10 |
| 2017-02-03 | 53.57M shares 10-K · filed 2017-02-23 |
| 2016-10-27 | 39.19M shares 10-Q · filed 2016-11-08 |
| 2016-07-29 | 39.05M shares 10-Q · filed 2016-08-08 |
| 2016-04-26 | 36.66M shares 10-Q · filed 2016-05-05 |
| 2016-02-04 | 36.23M shares 10-K · filed 2016-02-19 |
| 2015-10-26 | 35.97M shares 10-Q · filed 2015-11-06 |
| 2015-07-23 | 35.69M shares 10-Q · filed 2015-08-07 |
| 2015-04-28 | 29.63M shares 10-Q · filed 2015-05-08 |
| 2015-03-02 | 29.53M shares 10-K · filed 2015-03-13 |
| 2014-10-29 | 29.18M shares 10-Q · filed 2014-11-06 |
| 2014-07-29 | 28.91M shares 10-Q · filed 2014-08-04 |
| 2014-04-28 | 23.90M shares 10-Q · filed 2014-05-12 |
| 2014-02-28 | 23.72M shares 10-K · filed 2014-03-07 |
| 2013-10-31 | 313.62M shares 10-Q · filed 2013-11-12 |
| 2013-07-31 | 306.97M shares 10-Q · filed 2013-08-08 |
| 2013-04-30 | 305.63M shares 10-Q · filed 2013-05-10 |
| 2013-02-27 | 305.63M shares 10-K · filed 2013-03-01 |
| 2012-10-31 | 302.21M shares 10-Q · filed 2012-11-05 |
| 2012-07-31 | 302.21M shares 10-Q · filed 2012-08-09 |
| 2012-04-30 | 200.05M shares 10-Q · filed 2012-05-10 |
| 2012-02-29 | 200.05M shares 10-K · filed 2012-03-26 |
| 2011-10-31 | 200.02M shares 10-Q · filed 2011-11-07 |
| 2011-07-31 | 200.02M shares 10-Q · filed 2011-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |